Aspire BioPharma, Inc. — Form D

Aspire BioPharma, Inc. of HUMACAO, PR, a company, filed a Form D exempt-offering notice with the SEC on 2023-11-01. The offering totals $10.0M. Industry: Pharmaceuticals.

Offering

• Filed: 2023-11-01
• Form: D
• Accession: 0001493152-23-038912
• Industry: Pharmaceuticals
• Exemptions: 06c
• Total offering: $10.0M
• Remaining: $10.0M
• Minimum investment: $25K
• Security types: equity
• Revenue range: No Revenues
• SEC file number: 021-496221

Issuer

• Name: Aspire BioPharma, Inc.
• CIK: 0001995528
• Entity type: Corporation
• Jurisdiction: PUERTO RICO
• Incorporated: 2021
• Address: 194 CANDELERO DRIVE, #223, HUMACAO, PR, 00797
• Phone: 801-427-1111

Officers, directors & promoters (8)

More

• CIK 1995528 on SEC EDGAR (source of record)
• This page as markdown (for LLM agents)
• Search all SEC filings, advisers and people on Adviser Search